Crunching the numbers for COGT... Refresh in a moment for the full analysis.
Cogent Biosciences, Inc. (COGT)
Healthcare
mixed
$36.37
Updated: 2026-04-12
51
TradeApes Score
hold
Financial Strength
60
Healthy
Operating Trend
30
Weak
Valuation
50
Mixed
Capital Allocation
50
Mixed
Risk
80
Strong
Key Findings
+
Low leverage — net debt/EBITDA below 1×
−
FCF deteriorating — free cash flow down more than 25% year over year
See the full analysis
Quarterly financials, DCF valuation model, Watchlist, and Stock Screener.
Create Free Account
Scores and valuations are model outputs, not investment advice. TradeApes does not provide financial, tax, or investment advice.